Mean platelet volume predicts embolic complications and prognosis in infective endocarditis

International Journal of Infectious Diseases

Volumn 14, Issue 11, 2010, Pages

  Gunebakmaz, Ozgur ^a   Kaya, Mehmet Gungor ^a   Kaya, Esma Gunduz ^b   Ardic, Idris ^a   Yarlioglues, Mikail ^a   Dogdu, Orhan ^a   Kalay, Nihat ^a   Akpek, Mahmut ^a   Sarli, Bahadir ^a   Ozdogru, Ibrahim ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Embolic complication; Infective endocarditis; Mean platelet volume

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; DISEASE COURSE; EMBOLISM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; THROMBOCYTE VOLUME;

ADULT; BLOOD PLATELETS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; EMBOLISM; ENDOCARDITIS, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78149467811     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.05.019     Document Type: Article

References (38)

1. Hoen B., Alla F., Selton-Suty C., Béguinot I., Bouvet A., Briançon S., et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288:75-81.
2. Moreillon P., Que Y.A. Infective endocarditis. Lancet 2004, 363:139-149.
3. Tleyjeh I.M., Steckelberg J.M., Murad H.S., Anavekar N.S., Ghomrawi H.M., Mirzoyev Z., et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022-3028.
4. Nissen H., Nielsen P.F., Frederiksen M., Helleberg C., Nielsen J.S. Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980s. Eur Heart J 1992, 13:872-877.
5. Hart R.G., Foster J.W., Luther M.F., Kanter M.C. Stroke in infective endocarditis. Stroke 1990, 21:695-700.
6. Stewart J.A., Silimperi D., Harris P., Wise N.K., Fraker T.D., Kisslo J.A. Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation 1980, 61:374-380.
7. Ileri M., Alper A., Senen K., Durmaz T., Atak R., Hisar I., et al. Effect of infective endocarditis on blood coagulation and platelet activation and comparison of patients with to those without embolic events. Am J Cardiol 2003, 91:689-692.
8. Kupferwasser L.I., Hafner G., Mohr-Kahaly S., Erbel R., Meyer J., Darius H. The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 1999, 33:1365-1371.
9. Sandhaus L.M., Meyer P. How useful are CBC and reticulocyte reports to clinicians?. Am J Clin Pathol 2002, 118:787-793.
10. Bath P.M., Butterworth R.J. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996, 7:157-161.
11. Kapsoritakis A.N., Koukourakis M.I., Sfiridaki A., Potamianos S.P., Kosmadaki M.G., Koutroubakis I.E., et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001, 96:776-781.
12. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
13. Duval X., Leport C. Prophylaxis of infective endocarditis: current tendencies, continuing controversies. Lancet Infect Dis 2008, 8:225-232.
14. Thiene G., Basso C. Pathology and pathogenesis of infective endocarditis in native heart valves. Cardiovasc Pathol 2006, 15:256-263.
15. Bashore T.M., Cabell C., Fowler V. Update on infective endocarditis. Curr Probl Cardiol 2006, 31:274-352.
16. Yavuz S.S., Eren M., Yavuz A., Biçer Y., Koçak F., Bilgen F., et al. Infective endocarditis: evaluation of 58 cases (in Turkish). Klimik Dergisi 2003, 16:55-62.
17. Hoesley C.J., Cobbs C.G. Endocarditis at the millennium. J Infect Dis 1999, 179(Suppl 2):360-363.
18. Moreillon P. Endocarditis and endarteritis. Infectious diseases 1999, Mosby, London, p. 2.50.1-2.50.10. D. Armstrong, J. Cohen (Eds.).
19. Hogevik H., Olaison L., Andersson R., Lindberg J., Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995, 74:324-339.
20. Cetinkaya Y., Akova M., Akalin H.E., Aşçioĝlu S., Hayran M., Uzuns O., et al. A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common. Int J Antimicrob Agents 2001, 18:1-7.
21. Çaylan R., Aydi{dotless}n K., Kaygusuz S., Köksal I., Orem C. Otuziki infektif endokardit ataĝi{dotless}ni{dotless}n deĝerlendirilmesi. Flora 2001, 6:267-273.
22. Jones H.R., Siekert R.G. Neurological manifestations of infective endocarditis: review of clinical and therapeutic challenges. Brain 1989, 112:1295-1315.
23. Jaffe W.M., Morgan D.E., Pearlman A.S., Otto C.M. Infective endocarditis, 1983-1988: echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol 1990, 15:1227-1233.
24. Anavekar N.S., Tleyjeh I.M., Anavekar N.S., Mirzoyev Z., Steckelberg J.M., Haddad C., et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007, 44:1180-1186.
25. Chan K.L., Dumesnil J.G., Cujec B., Sanfilippo A.J., Jue J., Turek M.A., et al. Investigators of the Multicenter Aspirin Study in Infective Endocarditis. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003, 42:775-780.
26. Valtonen V., Kuikka A., Syrjänen J. Thrombo-embolic complications in bacteraemic infections. Eur Heart J 1993, 14:20-23.
27. Macko R.F., Ameriso S.F., Barndt R., Clough W., Weiner J.M., Fisher M. Precipitants of brain infarction: roles of preceding infection/inflammation and recent psychological stress. Stroke 1996, 27:1999-2004.
28. Syrjänen J., Valtonen V.V., Iivanainen M. Preceding infection as an important risk factor for ischemic brain infarction in young and middle aged patients. Br Med J 1988, 296:1156-1160.
29. Kamath S., Blann A.D., Lip G.Y. Platelet activation: assessment and quantification. Eur Heart J 2001, 22:1561-1571.
30. Yazici S., Yazici M., Erer B., Erer B., Calik Y., Bulur S., et al. The platelet functions in patients with ankylosing spondylitis: anti-TNF-alpha therapy decreases the mean platelet volume and platelet mass. Platelets 2010, 21:126-131.
31. Karabudak O., Ulusoy R.E., Erikci A.A., Solmazgul E., Dogan B., Harmanyeri Y. Inflammation and hypercoagulable state in adult psoriatic men. Acta Derm Venereol 2008, 88:337-340.
32. Yazici S., Yazici M., Erer B., Erer B., Calik Y., Ozhan H., et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010, 21:122-125.
33. Tozkoparan E., Deniz O., Ucar E., Bilgic H., Ekiz K. Changes in platelet count and indices in pulmonary tuberculosis. Clin Chem Lab Med 2007, 45:1009-1013.
34. Van der Lelie J., Von dem Borne A.K. Increased mean platelet volume in septicaemia. J Clin Pathol 1983, 36:693-696.
35. Dastugue N., Picheloup F., Sie P., Genestal M., Cathala B., Boneu B. Increase in mean platelet volume in shock-related thrombocytopenia. Nouv Presse Med 1982, 11:2899-2901.
36. Becchi C., Al Malyan M., Fabbri L.P., Marsili M., Boddi V., Boncinelli S. Mean platelet volume trend in sepsis: is it a useful parameter?. Minerva Anestesiol 2006, 72:749-756.
37. Wallace S.M., Walton B.I., Kharbanda R.K., Hardy R., Wilson A.P., Swanton R.H. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002, 88:53-60.
38. Inanç T., Kaya M.G., Kaya E.G., Doĝan A., Ardi{dotless}ç I., Doĝdu O., et al. Infective endocarditis: retrospective evaluation of 27 patients (in Turkish). Ti{dotless}p Araşti{dotless}rmalari{dotless} Dergisi 2007, 5:91-99.